Guardant Health GH Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 64.9%+3.6pp | 64.5%+3.7pp | 63.8%+4.6pp | 62.8%+4.4pp | 61.3%+2.4pp | |
| Operating margin | -41.4%+17.3pp | -44.5%+15.5pp | -49%+25.4pp | -55.6%+23.8pp | -58.8%+29.1pp | |
| Net margin | -40.1%+13.7pp | -42.4%+16.7pp | -44.2%+29.8pp | -49.9%+26.3pp | -53.8%+22.5pp | |
| EBITDA margin | -37.8%+15.5pp | -40.5%+13.8pp | -44.6%+23.7pp | -50.6%+22.1pp | -53.4%+27.3pp | |
| Free cash flow margin | -22%+17.4pp | -23.7%+13.5pp | -29.1%+10.6pp | -32.8%+13.7pp | -39.4%+10.4pp | |
| Returns | ||||||
| Return on assets | -26.6%+0.7pp | -23.8%+2.9pp | -28.3%+2.4pp | -28.1%+0.3pp | -27.3%+1.3pp | |
| Return on invested capital | -132.8%— | -51.8%— | —— | —— | —— | |
| Efficiency | ||||||
| Asset turnover | 0.7×+0.2× | 0.6×+0.1× | 0.6×+0.2× | 0.6×+0.2× | 0.5×+0.1× | |
| Inventory turnover | 4.7×+0.4× | 4.4×+0.1× | 4×+0.4× | 4.1×+0.1× | 4.3×0.0× | |
| Liquidity | ||||||
| Current ratio | 4.7×+0.6× | 4.8×+0.2× | 3.5×-2.7× | 3.7×-2.7× | 4.1×-1.8× | |
| Quick ratio | 4.4×+0.6× | 4.6×+0.2× | 3.1×-2.7× | 3.4×-2.7× | 3.8×-1.9× | |
| Cash ratio | 3.8×+0.2× | 1.6×-1.2× | 2.9×-0.6× | 3.1×-2.1× | 3.6×-1.6× | |
| Leverage | ||||||
| Debt-to-assets | 0.9×-0.1× | 0.8×0.0× | 1×+0.9× | 1×+0.9× | 1×+0.9× | |
| Interest coverage | -100.5×+66.3× | -112.2×+59.7× | -131.6×+68.0× | -150.3×+48.0× | -166.8×+38.8× | |
| Per Share | ||||||
| Book value per share | -$1.38+31.9% | -$0.79+30.4% | -$2.84-482% | -$2.46-18,545% | -$2.02-461% | |
| Valuation | ||||||
| Market capitalization | $12.12B+130% | $13.27B+251% | $7.79B+176% | $6.19B+75.2% | $5.26B+109% | |
| Enterprise value | $12.72B+121% | $14.49B+223% | $8.43B+262% | $6.79B+152% | $5.76B+263% | |
| Price / sales | 11.2×+4.4× | 13.5×+8.4× | 8.6×+4.6× | 7.5×+2.0× | 6.8×+2.6× | |
| EV / sales | 11.8×+4.3× | 14.8×+8.7× | 9.3×+6.0× | 8.2×+4.0× | 7.4×+4.8× | |
| Free cash flow yield | -2%+3.8pp | -1.8%+5.5pp | -3.4%+6.4pp | -4.4%+4.1pp | -5.8%+6.2pp | |
| Earnings yield | -3.6%+4.3pp | -3.1%+8.4pp | -5.1%+13.0pp | -6.7%+7.2pp | -7.9%+10.4pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Guardant Health's profit margins?
- Guardant Health (GH) runs a 64.9% gross margin and a -41.4% operating margin, with a -40.1% net margin.
- Where do Guardant Health's ratios come from?
- Every ratio is computed from Guardant Health's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
